OPTN Bathi mangsa ngarep OptiNose Inc

Simbol resmi perusahaan OptiNose Inc (OPTN)

Automation of medical system assembly lines reduces personnel costs, which strengthens the monetization of patents for nasal devices used to treat sinusitis for OptiNose, Inc. (OPTN). The projected growth in net profit confirms this trend, and the indicator has reached the level of 0.01. Business stability is supported by diversified component supplies and long-term contracts for fluticasone formulas, eliminating production downtime.

optinose.com (OPTN): Bathi resik sing dikarepake saka 13.04.2025 nganti 31.05.2025

Optinose - rincian analitis lan metrik utama (OPTN)

- rega saham lan konsensus proyeksi valuasi:
Analisis fundamental perusahaan:OPTN, OptiNose
Produk dadi OptiNose Inc

For OptiNose, Inc. (OPTN), the expected earnings trajectory reflects the monetization potential of its unique nasal drug delivery system. This indicator assesses future cash flows based on corporate return forecasts. The metric's calculation accounts for patent-protected revenue against conventional sprays to determine fundamental value. This analysis allows for the verification of market expectations. Overstated forecasts in the event of failure risk investor overpayment and capital freeze.

Analisis pesaing OptiNose, Inc.

Bathi mangsa ngarep HLN|Proyeksi bathi mangsa ngarep Kenvue Corp|Bathi mangsa ngarep VRNA (Verona Pharma Corp)|MENS (Jyong Bio) - Penghasilan resik sing dikarepake|Bathi sing dikarepake Ligand Pharmaceuticals Incorporated LGND|Amneal (AMRX) - Bathi resik sing dikarepake|PRGO: Bathi mangsa ngarep|Alvotech SA - Bathi resik mangsa ngarep|LQDA: Proyeksi bathi mangsa ngarep|Galapagos Genomics - Penghasilan resik sing dikarepake|ANIP (ANI Pharmaceuticals Inc) - Proyeksi bathi mangsa ngarep|Bathi resik sing dikarepake mannkindcorp.com MNKD|Bathi sing dikarepake Amphastar Pharmaceuticals, Inc. (AMPH)|PCRX (Pacira Pharmaceuticals) - Penghasilan resik sing dikarepake|Proyeksi bathi mangsa ngarep SPRY (ARS Pharmaceuticals Inc)|Bathi resik mangsa ngarep TBPH (Theravance)|AQST - Bathi sing dikarepake|scPharmaceuticals (SCPH) - Bathi mangsa ngarep|TECX: Proyeksi bathi mangsa ngarep|Prakiraan bathi resik TNXP|Bathi sing dikarepake China SXT Pharmaceuticals, Inc.|EPRX: Penghasilan resik sing dikarepake|Proyeksi bathi mangsa ngarep BHST|EXOZ - Bathi resik sing dikarepake|Proyeksi bathi mangsa ngarep ORMP (oramed.com)|Proyeksi bathi mangsa ngarep enterabio.com ENTX|HYFT - Bathi sing dikarepake|Prakiraan bathi perusahaan ABVC BioPharma, Inc ABVC|CPIX: Proyeksi bathi mangsa ngarep|Quantum BioPharma Ltd - Penghasilan resik sing dikarepake|Bathi mangsa ngarep FGEN|Telomir Pharmaceuticals, Inc. - Bathi forward|Proyeksi bathi mangsa ngarep RANI|SNYR (Synergy CHC) - Penghasilan resik sing dikarepake|Bathi sing dikarepake Rallybio RLYB|Lexaria Bioscience (LEXX) - Bathi resik sing dikarepake|PULM - Bathi sing dikarepake|Prakiraan bathi perusahaan Pheton Holdings PTHL|APM (Aptorum) - Bathi mangsa ngarep|Lyra Therapeutics, Inc. (LYRA) - Proyeksi bathi mangsa ngarep|IBO (impactbiomedinc.com) - Proyeksi bathi mangsa ngarep|TNFA (TNF Pharmaceuticals) - Bathi resik mangsa ngarep|Bathi sing dikarepake cbdmd.com (YCBD)|Prakiraan bathi perusahaan PainReform Ltd|Proyeksi bathi mangsa ngarep CYTO (Altamira Therapeutics Ltd.)|Lipella Pharmaceuticals (LIPO) - Bathi resik sing dikarepake|PIRS: Bathi mangsa ngarep|PROC - Proyeksi bathi mangsa ngarep|PTPI: Proyeksi bathi mangsa ngarep|Qilian International Holding Group (QLI) - Proyeksi bathi mangsa ngarep|SLRN (ACELYRIN, Inc.) - Proyeksi bathi mangsa ngarep|TFF Pharmaceuticals (TFFP) - Prakiraan bathi perusahaan